Table 1 Summary of the samples available concerning the 79 patients included in the study
From: NRAS Q61R, BRAF V600E immunohistochemistry: a concomitant tool for mutation screening in melanomas
Both primary tumor and metastasis | 33 |
More than one metastasis without primary melanoma | 5 |
Only one metastasis without primary melanoma | 26 |
Only primary melanoma | 15 |